[ad_1]
![A woman in a green dress holding her pregnant belly](https://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1718370114283_mainnews2012_x1.jpg)
From new 6G signal processing technology to the Diversity Symposium and Cystic Fibrosis funding, here’s a quick rundown of the latest news from across Imperial.
Paving the way for 6G communications
A new signal processing technique for wireless communications developed at Imperial College London has shown to outperform alternative methods and could pave the way for use in 6G. The technique, called Rate Division Multiple Access (RSMA), was invented and developed in the laboratory of Professor Bruno Clarks in the School of Electrical and Electronic Engineering.
A key challenge for modern wireless communication systems such as 5G is the “multiple access problem”: how to serve as many users as possible simultaneously to meet the huge demand for mobile connectivity. The key is to overcome the interference caused by signals intended for other users during each use. RSMA would allow cell towers to better manage interference, in principle allowing higher data rates than are currently possible with state-of-the-art 5G.
Now, experimental results published in a new paper in IEEE Transactions on Wireless Communications show that this is true, making it a promising technology for future wireless networks such as 6G.
Diversity Symposium
The Faculty of Natural Sciences hosted a research symposium on 4 June, the largest event celebrating diversity at the University. Changing the Face of Science, the research symposium featured research findings and journeys from researchers from groups historically underrepresented in STEM fields across 18 faculties at Imperial College.
The symposium kicked off with a panel discussion on research careers, where speakers shared their candid views on the benefits and challenges they have faced. Panelists included Dr. Sarah Essilfi Quaye (National Heart and Lung Institute, photo top left); Professor Faith Oshie (Life Sciences)Dr. Mark Richards (Physics)With Professor Richard Craster (Dean of the School of Natural Sciences) and Dr Calvin Tiengwe (Life Sciences).The session was chaired by Dr Bernadette Byrne, Associate Dean, EDI, Faculty of Natural Sciences.
“Events like this symposium help raise the profile of researchers from underrepresented groups and inspire and inspire other researchers,” Dr. Richards said.
Awards were also presented to students and staff researchers on the day and the recipients included Hemali Chauhan from the Department of Surgery and Oncology, Davide Nodari from the Department of Chemistry, Miriam Prasow Emond from the Department of Geosciences and Engineering, Rupali Dabas from the Department of Chemistry and Shubha Talwar from the National Heart and Lung Institute.
Cystic Fibrosis Funding
Researchers at Imperial College have been awarded an £800,000 grant from the Cystic Fibrosis Foundation to investigate the impact of pregnancy, childbirth and breastfeeding on women with cystic fibrosis (CF).
Professor Jane Davies and Dr Imogen Felton, both from the National Heart and Lung Institute and the Royal Brompton Hospital, will focus on how CF regulators taken by pregnant women can affect both their baby’s and their own health.
This groundbreaking group of medicines has increased life expectancy for CF patients and improved the chances of pregnancy for women with CF, but the drugs themselves have not been approved or tested for use during pregnancy.
Professor Davies, Professor of Paediatric Pulmonology and Experimental Medicine at the NHLI, explained: “This funding will help us continue the important research we are doing to support women with cystic fibrosis to make better decisions about their reproductive health. “The funding is part of a total £2 million funding package from the charity targeted at research priorities identified by people with cystic fibrosis.
Want to stay up to date with the latest Imperial news?
Sign up for our free daily e-newsletter, Imperial Today..
[ad_2]
Source link